Litcius/Paper detail

Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease

Patrick B. Mark, Naveed Sattar

2022The Lancet12 citationsDOI

Topics & Concepts

Kidney diseaseMedicineIntensive care medicineDiseaseMEDLINEInternal medicinePolitical scienceLawDiabetes Treatment and ManagementPotassium and Related DisordersHeart Failure Treatment and Management
Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease | Litcius